Skip to main content
Equibles
SBRA logo

SBRA · Sabra Health Care REIT, Inc. · Analyst Estimates

Track SBRA — free

Use SBRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SBRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.09 +0.74 (+3.64%) At close · Nov 4 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.52B
Shares
261.96M
Volume · Nov 4 5.53M Avg daily vol (3M) 2.41M

Analyst Estimates

Compare analyst forecasts for Sabra Health Care REIT, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-04 13:15 UTC · Publication dates shown per estimate · 6 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.38
0.40
0.44
8
0.45
0.48
0.59
0.69
2
3
0
1
Revenue
USD
Publication date not stated
910.90M
926.51M
965.06M
7
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.77
0.81
0.85
2
0.78
0.76
0.74
0.74
0
0
1
1
Revenue
USD
Publication date not stated
961.80M
1.02B
1.14B
7
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.16
0.20
0.18
0.20
0.18
0.20
2
3
0.17
0.18
0.17
0.18
0.17
0.18
0.17
0.17
1
0
1
0
0
1
0
1
Revenue
USD
Publication date not stated
236.00M
241.13M
243.29M
250.43M
260.57M
272.94M
7
6
 — — — — — — — —
Key facts CIK 1492298 CUSIP 78573L106 13F (30d) 190 filings 162 filers Visit website Investor relations